Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	neutral L-amino acid:sodium symporter activity	SLC38A2 SLC38A4 SLC38A3	5.74e-06	8	95	3	GO:0005295
GeneOntologyMolecularFunction	alanine transmembrane transporter activity	SLC38A2 SLC38A4 SLC38A3	5.59e-05	16	95	3	GO:0022858
GeneOntologyMolecularFunction	carbon-sulfur lyase activity	CENPVL2 CENPVL3 CENPVL1	5.59e-05	16	95	3	GO:0016846
GeneOntologyMolecularFunction	alanine:sodium symporter activity	SLC38A2 SLC38A4	1.34e-04	4	95	2	GO:0015655
GeneOntologyMolecularFunction	amino acid:sodium symporter activity	SLC38A2 SLC38A4 SLC38A3	1.72e-04	23	95	3	GO:0005283
GeneOntologyMolecularFunction	amino acid:monoatomic cation symporter activity	SLC38A2 SLC38A4 SLC38A3	3.48e-04	29	95	3	GO:0005416
GeneOntologyMolecularFunction	lyase activity	APIP CENPVL2 RNASE1 CENPVL3 GUCY1A1 CENPVL1	5.29e-04	212	95	6	GO:0016829
GeneOntologyMolecularFunction	L-glutamine transmembrane transporter activity	SLC38A2 SLC38A3	7.89e-04	9	95	2	GO:0015186
GeneOntologyMolecularFunction	neutral L-amino acid transmembrane transporter activity	SLC38A2 SLC38A4 SLC38A3	9.75e-04	41	95	3	GO:0015175
Domain	Actin	ACTL8 ACTBL2 ACTG2 ACTR2	1.50e-05	31	91	4	IPR004000
Domain	Actin	ACTL8 ACTBL2 ACTG2 ACTR2	1.50e-05	31	91	4	PF00022
Domain	ACTIN	ACTL8 ACTBL2 ACTG2 ACTR2	1.50e-05	31	91	4	SM00268
Domain	Kinase-like_dom	TRPM6 MET PIK3C2B IKBKE SGK1 TESK2 SMARCC1 MACF1 KDR PRKDC EPHA1	6.45e-05	542	91	11	IPR011009
Domain	Aa_trans	SLC38A2 SLC38A4 SLC38A3	7.24e-05	17	91	3	PF01490
Domain	AA_transpt_TM	SLC38A2 SLC38A4 SLC38A3	7.24e-05	17	91	3	IPR013057
Domain	Actin/actin-like_CS	ACTBL2 ACTG2 ACTR2	8.66e-05	18	91	3	IPR020902
Domain	ACTINS_ACT_LIKE	ACTBL2 ACTG2 ACTR2	1.02e-04	19	91	3	PS01132
Domain	ACTINS_1	ACTBL2 ACTG2	6.45e-04	8	91	2	PS00406
Domain	RecF/RecN/SMC_N	SMC5 SMC1B	6.45e-04	8	91	2	IPR003395
Domain	SMC_N	SMC5 SMC1B	6.45e-04	8	91	2	PF02463
Domain	VWF_dom	VWF PXDNL OTOG	1.12e-03	42	91	3	IPR001007
Domain	PROTEIN_KINASE_TYR	MET TESK2 KDR EPHA1	1.29e-03	97	91	4	PS00109
Domain	Tyr_kinase_AS	MET TESK2 KDR EPHA1	1.29e-03	97	91	4	IPR008266
Domain	ARM-type_fold	IPO7 PIK3C2B PRKDC WDFY3 HUWE1 PPP4R4 RYR3	1.34e-03	339	91	7	IPR016024
Domain	C8	VWF OTOG	1.50e-03	12	91	2	PF08742
Domain	TIL	VWF OTOG	1.50e-03	12	91	2	PF01826
Domain	Unchr_dom_Cys-rich	VWF OTOG	1.77e-03	13	91	2	IPR014853
Domain	C8	VWF OTOG	1.77e-03	13	91	2	SM00832
Domain	TIL_dom	VWF OTOG	2.06e-03	14	91	2	IPR002919
Domain	EF-hand_like	PLCB2 PLCL1	2.37e-03	15	91	2	PF09279
Domain	PI-PLC-Y	PLCB2 PLCL1	2.37e-03	15	91	2	PF00387
Domain	PLCYc	PLCB2 PLCL1	2.37e-03	15	91	2	SM00149
Domain	PI3/4_kinase_CS	PIK3C2B PRKDC	2.37e-03	15	91	2	IPR018936
Domain	PLipase_C_Pinositol-sp_Y	PLCB2 PLCL1	2.37e-03	15	91	2	IPR001711
Domain	PIPLC_Y_DOMAIN	PLCB2 PLCL1	2.37e-03	15	91	2	PS50008
Domain	PI-PLC_fam	PLCB2 PLCL1	2.37e-03	15	91	2	IPR001192
Domain	PLC_EF-hand-like	PLCB2 PLCL1	2.37e-03	15	91	2	IPR015359
Domain	VWF_type-D	VWF OTOG	2.70e-03	16	91	2	IPR001846
Domain	-	PIK3C2B PRKDC	2.70e-03	16	91	2	1.10.1070.11
Domain	VWFD	VWF OTOG	2.70e-03	16	91	2	PS51233
Domain	PI3Kc	PIK3C2B PRKDC	2.70e-03	16	91	2	SM00146
Domain	VWD	VWF OTOG	2.70e-03	16	91	2	SM00216
Domain	Actin_CS	ACTBL2 ACTG2	2.70e-03	16	91	2	IPR004001
Domain	VWD	VWF OTOG	2.70e-03	16	91	2	PF00094
Domain	-	IGFBP4 TG	3.04e-03	17	91	2	4.10.800.10
Domain	Thyroglobulin_1	IGFBP4 TG	3.04e-03	17	91	2	IPR000716
Domain	THYROGLOBULIN_1_1	IGFBP4 TG	3.04e-03	17	91	2	PS00484
Domain	ACTINS_2	ACTBL2 ACTG2	3.04e-03	17	91	2	PS00432
Domain	TY	IGFBP4 TG	3.04e-03	17	91	2	SM00211
Domain	THYROGLOBULIN_1_2	IGFBP4 TG	3.04e-03	17	91	2	PS51162
Domain	Thyroglobulin_1	IGFBP4 TG	3.04e-03	17	91	2	PF00086
Domain	PI3_PI4_kinase	PIK3C2B PRKDC	3.41e-03	18	91	2	PF00454
Domain	PI3_4_KINASE_1	PIK3C2B PRKDC	3.41e-03	18	91	2	PS00915
Domain	PI3_4_KINASE_2	PIK3C2B PRKDC	3.41e-03	18	91	2	PS00916
Domain	PI-PLC-X	PLCB2 PLCL1	3.41e-03	18	91	2	PF00388
Domain	PLCXc	PLCB2 PLCL1	3.41e-03	18	91	2	SM00148
Domain	PI3/4_kinase_cat_dom	PIK3C2B PRKDC	3.41e-03	18	91	2	IPR000403
Domain	PI3_4_KINASE_3	PIK3C2B PRKDC	3.41e-03	18	91	2	PS50290
Domain	Pkinase_Tyr	MET TESK2 KDR EPHA1	3.65e-03	129	91	4	PF07714
Domain	VWC_out	VWF OTOG	3.80e-03	19	91	2	SM00215
Domain	PIPLC_X_DOMAIN	PLCB2 PLCL1	3.80e-03	19	91	2	PS50007
Domain	PLipase_C_PInositol-sp_X_dom	PLCB2 PLCL1	3.80e-03	19	91	2	IPR000909
Domain	Ser-Thr/Tyr_kinase_cat_dom	MET TESK2 KDR EPHA1	4.64e-03	138	91	4	IPR001245
Domain	PH_dom-like	ANKS1B PLCB2 PLCL1 WDFY3 EPB41L3 SH2D5 MTMR9	4.78e-03	426	91	7	IPR011993
Pathway	KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY	PLCB2 TSHB TG	2.95e-05	12	74	3	M47628
Pubmed	Improving GENCODE reference gene annotation using a high-stringency proteogenomics workflow.	CENPVL2 CENPVL3 CENPVL1	3.93e-07	6	95	3	27250503
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	IPO7 STRAP SMARCC1 BEND3 CHD3 NUP214 HUWE1 GTF3C3 ZFPM2	5.76e-06	469	95	9	27634302
Pubmed	Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma.	MET KDR	7.38e-06	2	95	2	30719715
Pubmed	Thrombin-mediated in vitro processing of pro-von Willebrand factor.	VWF F2	7.38e-06	2	95	2	11776313
Pubmed	The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab.	MET KDR	7.38e-06	2	95	2	33727583
Pubmed	Epac1 regulates TLR4 signaling in the diabetic retinal vasculature.	RAPGEF3 TLR4	7.38e-06	2	95	2	34020266
Pubmed	Flow and delta-P dictate where thrombin, fibrin, and von Willebrand Factor will be found.	VWF F2	7.38e-06	2	95	2	27207416
Pubmed	Properties and regulation of glutamine transporter SN1 by protein kinases SGK and PKB.	SGK1 SLC38A3	7.38e-06	2	95	2	12788082
Pubmed	The mechanism of melanoma-associated thrombin activity and von Willebrand factor release from endothelial cells.	VWF F2	7.38e-06	2	95	2	20505748
Pubmed	Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis.	EFNB2 KDR	7.38e-06	2	95	2	20445540
Pubmed	Induction of microglial toll-like receptor 4 by prothrombin kringle-2: a potential pathogenic mechanism in Parkinson's disease.	TLR4 F2	7.38e-06	2	95	2	26440368
Pubmed	An endothelial TLR4-VEGFR2 pathway mediates lung protection against oxidant-induced injury.	TLR4 KDR	7.38e-06	2	95	2	26655705
Pubmed	Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients.	MET KDR	7.38e-06	2	95	2	27789775
Pubmed	HMQ-T-B10 induces human liver cell apoptosis by competitively targeting EphrinB2 and regulating its pathway.	EFNB2 KDR	7.38e-06	2	95	2	30589500
Pubmed	Regulation of Thrombin-Induced Lung Endothelial Cell Barrier Disruption by Protein Kinase C Delta.	PRKDC F2	7.38e-06	2	95	2	27442243
Pubmed	Thrombin generation in the presence of platelets is sensitive to the activation status of von Willebrand factor.	VWF F2	7.38e-06	2	95	2	25274249
Pubmed	A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activities.	MET KDR	7.38e-06	2	95	2	23548264
Pubmed	MASP-1 of the complement system promotes clotting via prothrombin activation.	MASP1 F2	7.38e-06	2	95	2	25745807
Pubmed	EphrinB2 regulates VEGFR2 during dendritogenesis and hippocampal circuitry development.	EFNB2 KDR	7.38e-06	2	95	2	31868584
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ACTBL2 LPCAT4 MARF1 ANKS1B SMARCC1 ACTG2 BEND3 MACF1 KDR CHD3 PRKDC EPB41L3 ACTR2 PPP4R4 RING1	8.36e-06	1442	95	15	35575683
Pubmed	Evolutionary origin of amino acid transporter families SLC32, SLC36 and SLC38 and physiological, pathological and therapeutic aspects.	SLC38A2 SLC38A4 SLC38A3	8.77e-06	15	95	3	23506890
Pubmed	Subepicardial endothelial cells invade the embryonic ventricle wall to form coronary arteries.	EFNB2 KDR ZFPM2	8.77e-06	15	95	3	23797856
Pubmed	Serum and glucocorticoid-inducible kinase 1 (SGK1) is necessary for vascular remodeling during angiogenesis.	EFNB2 SGK1 KDR	8.77e-06	15	95	3	20568246
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	APEX2 PIK3C2B IKBKE UBA6 NUP214 EPB41L3 SMC5 F2 RYR3	9.16e-06	497	95	9	36774506
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	IPO7 SMARCC1 BEND3 MACF1 NUP214 PRKDC HUWE1 EPB41L3 ACTR2 GTF3C3	1.23e-05	653	95	10	22586326
Pubmed	Maintenance of silent chromatin through replication requires SWI/SNF-like chromatin remodeler SMARCAD1.	SMARCC1 BEND3 PRKDC GTF3C3 RING1	1.73e-05	116	95	5	21549307
Pubmed	SRG3, a core component of mouse SWI/SNF complex, is essential for extra-embryonic vascular development.	EFNB2 SMARCC1 KDR	1.85e-05	19	95	3	18206867
Pubmed	A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis.	SLC38A2 IPO7 ACTBL2 PRKDC ACTR2	1.87e-05	118	95	5	27377895
Pubmed	FOXF1 transcription factor is required for formation of embryonic vasculature by regulating VEGF signaling in endothelial cells.	VWF EFNB2 KDR	2.18e-05	20	95	3	25091710
Pubmed	Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model.	VWF F2	2.21e-05	3	95	2	17380206
Pubmed	Gut microbiota regulate hepatic von Willebrand factor synthesis and arterial thrombus formation via Toll-like receptor-2.	VWF TLR4	2.21e-05	3	95	2	28572286
Pubmed	High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.	VWF KDR	2.21e-05	3	95	2	7681362
Pubmed	Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients.	VWF TLR4	2.21e-05	3	95	2	17849054
Pubmed	Revisiting Libman-Sacks endocarditis: a historical review and update.	PLCB2 F2	2.21e-05	3	95	2	19089657
Pubmed	EPAC and PKA allow cAMP dual control over DNA-PK nuclear translocation.	RAPGEF3 PRKDC	2.21e-05	3	95	2	18728186
Pubmed	Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET.	MET TLR4	2.21e-05	3	95	2	24567328
Pubmed	Antenatal dexamethasone treatment in midgestation reduces system A-mediated transport in the late-gestation murine placenta.	SLC38A2 SLC38A4	2.21e-05	3	95	2	21733830
Pubmed	Cardiovascular ephrinB2 function is essential for embryonic angiogenesis.	EFNB2 KDR	2.21e-05	3	95	2	11880349
Pubmed	Co-localization of prothrombin fragment F1+2 and VEGF-R2-bound VEGF in human colon cancer.	KDR F2	2.21e-05	3	95	2	21498704
Pubmed	NOD-scid IL2rγnull mice lacking TLR4 support human immune system development and the study of human-specific innate immunity.	TLR4 PRKDC	2.21e-05	3	95	2	36801998
Pubmed	MET Suppresses Epithelial VEGFR2 via Intracrine VEGF-induced Endoplasmic Reticulum-associated Degradation.	MET KDR	2.21e-05	3	95	2	26137585
Pubmed	The c-MET receptor tyrosine kinase contributes to neutrophil-driven pathology in cutaneous leishmaniasis.	MET TLR4	2.21e-05	3	95	2	35041723
Pubmed	HUWE1-dependent DNA-PKcs neddylation modulates its autophosphorylation in DNA damage response.	PRKDC HUWE1	2.21e-05	3	95	2	32457294
Pubmed	Lymphangiogenesis in the developing lung promoted by VEGF-A.	EFNB2 KDR	2.21e-05	3	95	2	16806288
Pubmed	Vascular endothelial growth factor (VEGF) receptor-2 tyrosine 1175 signaling controls VEGF-induced von Willebrand factor release from endothelial cells via phospholipase C-gamma 1- and protein kinase A-dependent pathways.	VWF KDR	2.21e-05	3	95	2	19570985
Pubmed	Dual inhibition using cabozantinib overcomes HGF/MET signaling mediated resistance to pan-VEGFR inhibition in orthotopic and metastatic neuroblastoma tumors.	MET KDR	2.21e-05	3	95	2	27922668
Pubmed	A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis.	MET KDR	2.21e-05	3	95	2	19773544
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	TRPM6 SLC38A2 IPO7 PITRM1 STRAP UBA6 SMARCC1 NUP214 PRKDC HUWE1 EPB41L3 F2 ACTR2 GTF3C3	3.23e-05	1425	95	14	30948266
Pubmed	Hand2 is an essential regulator for two Notch-dependent functions within the embryonic endocardium.	EFNB2 KDR ZFPM2	3.83e-05	24	95	3	25497097
Pubmed	Identification of tyrosine kinases expressed in the male mouse gubernaculum during development.	MET KDR EPHA1	4.35e-05	25	95	3	15254900
Pubmed	Differential regulation of alternate promoter regions in Sox17 during endodermal and vascular endothelial development.	EFNB2 KDR HNF4A	4.35e-05	25	95	3	36046192
Pubmed	Histoplasma capsulatum cell wall {beta}-glucan induces lipid body formation through CD18, TLR2, and dectin-1 receptors: correlation with leukotriene B4 generation and role in HIV-1 infection.	TLR4 ALOX5	4.41e-05	4	95	2	19299700
Pubmed	The evolution of SMC proteins: phylogenetic analysis and structural implications.	SMC5 SMC1B	4.41e-05	4	95	2	14660695
Pubmed	Amino acid transporter ATA2 is stored at the trans-Golgi network and released by insulin stimulus in adipocytes.	SLC38A2 SLC38A4	4.41e-05	4	95	2	17050538
Pubmed	Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer.	MET KDR	4.41e-05	4	95	2	28973887
Pubmed	VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex.	MET KDR	4.41e-05	4	95	2	22789536
Pubmed	A pilot study on prostate cancer risk and pro-inflammatory genotypes: pathophysiology and therapeutic implications.	TLR4 ALOX5	4.41e-05	4	95	2	20388081
Pubmed	Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.	MET KDR EPHA1	6.16e-05	28	95	3	18593464
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	STRAP NETO1 NISCH ANKS1B UBA6 SMARCC1 MACF1 PLCL1 WDFY3 HUWE1 EPB41L3	6.50e-05	963	95	11	28671696
Pubmed	Differential expression of vascular endothelial growth factor and its receptor mRNAs in the mouse uterus around the time of implantation.	VWF KDR	7.34e-05	5	95	2	7490564
Pubmed	Schlemm's canal is a unique vessel with a combination of blood vascular and lymphatic phenotypes that forms by a novel developmental process.	EFNB2 KDR	7.34e-05	5	95	2	25051267
Pubmed	Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo.	VWF F2	7.34e-05	5	95	2	16824188
Pubmed	Leukotriene B4 amplifies eosinophil accumulation in response to nematodes.	TLR4 ALOX5	7.34e-05	5	95	2	24889202
Pubmed	Toll-like receptor 4 protects against lethal Leptospira interrogans serovar icterohaemorrhagiae infection and contributes to in vivo control of leptospiral burden.	TLR4 PRKDC	7.34e-05	5	95	2	16428731
Pubmed	Functional characterization of transcription factor binding sites for HNF1-alpha, HNF3-beta (FOXA2), HNF4-alpha, Sp1 and Sp3 in the human prothrombin gene enhancer.	F2 HNF4A	7.34e-05	5	95	2	12911579
Pubmed	Analysis of the effects of HIV-1 Tat on the survival and differentiation of vessel wall-derived mesenchymal stem cells.	VWF KDR	7.34e-05	5	95	2	22095559
Pubmed	Adaptation of nutrient supply to fetal demand in the mouse involves interaction between the Igf2 gene and placental transporter systems.	SLC38A2 SLC38A4	7.34e-05	5	95	2	16365304
Pubmed	Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling.	MET KDR	7.34e-05	5	95	2	22897854
Pubmed	Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells.	EFNB2 PRKDC	7.34e-05	5	95	2	38569552
Pubmed	NM23-H1 tumor suppressor and its interacting partner STRAP activate p53 function.	STRAP SGK1	7.34e-05	5	95	2	17916563
Pubmed	β2-microglobulin functions as an endogenous NMDAR antagonist to impair synaptic function.	TLR4 PRKDC	7.34e-05	5	95	2	36868208
Pubmed	Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signaling.	TLR4 PRKDC	7.34e-05	5	95	2	23223360
Pubmed	Amino acid transport systems beta and A in fetal T lymphocytes in intrauterine growth restriction and with tumor necrosis factor-alpha treatment.	SLC38A2 SLC38A4	7.34e-05	5	95	2	18703994
Pubmed	A role for APPL1 in TLR3/4-dependent TBK1 and IKKε activation in macrophages.	IKBKE TLR4	7.34e-05	5	95	2	25780039
Pubmed	Amino acid transport across mammalian intestinal and renal epithelia.	SLC38A2 SLC38A4 SLC38A3	8.40e-05	31	95	3	18195088
Pubmed	The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function.	CACNA1D HUWE1 EPB41L3	1.01e-04	33	95	3	22357600
Pubmed	Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?	SGK1 DECR2 CHD3 HUWE1 OTOG	1.07e-04	170	95	5	23314748
Pubmed	Dosage-sensitive requirement for mouse Dll4 in artery development.	EFNB2 KDR	1.10e-04	6	95	2	15466159
Pubmed	A new chemical probe for quantitative proteomic profiling of fibroblast growth factor receptor and its inhibitors.	IKBKE KDR	1.10e-04	6	95	2	24184958
Pubmed	Proper coronary vascular development and heart morphogenesis depend on interaction of GATA-4 with FOG cofactors.	KDR ZFPM2	1.10e-04	6	95	2	11297508
Pubmed	Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis.	TLR4 PRKDC	1.10e-04	6	95	2	22902233
Pubmed	Rasip1 regulates vertebrate vascular endothelial junction stability through Epac1-Rap1 signaling.	RAPGEF3 KDR	1.10e-04	6	95	2	23886837
Pubmed	Arteriovenous malformations in mice lacking activin receptor-like kinase-1.	EFNB2 KDR	1.10e-04	6	95	2	11062473
Pubmed	Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity.	RNF123 UBA6 HUWE1 RING1	1.37e-04	95	95	4	29643511
Pubmed	Abnormal blood vessel development in mice lacking presenilin-1.	EFNB2 KDR	1.54e-04	7	95	2	12834865
Pubmed	Advancements and challenges in generating accurate animal models of gestational diabetes mellitus.	MET HNF4A	1.54e-04	7	95	2	24085033
Pubmed	mTORC1 controls the adaptive transition of quiescent stem cells from G0 to G(Alert).	MET PRKDC	1.54e-04	7	95	2	24870234
Pubmed	Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.	EFNB2 KDR	1.54e-04	7	95	2	9990854
Pubmed	TLR4 and C5aR crosstalk in dendritic cells induces a core regulatory network of RSK2, PI3Kβ, SGK1, and FOXO transcription factors.	SGK1 TLR4	1.54e-04	7	95	2	28733463
Pubmed	Spatial regulation of VEGF receptor endocytosis in angiogenesis.	EFNB2 KDR	1.54e-04	7	95	2	23354168
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	MET RNF123 STRAP IKBKE SGK1 SMARCC1 BCAR3 RUNX1T1 EPB41L3 HNF4A ACTR2 GTF3C3	1.97e-04	1284	95	12	17353931
Pubmed	HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells.	VWF KDR	2.05e-04	8	95	2	21612582
Pubmed	Paternal knockout of Slc38a4/SNAT4 causes placental hypoplasia associated with intrauterine growth restriction in mice.	SLC38A2 SLC38A4	2.05e-04	8	95	2	31570606
Pubmed	Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development.	VWF EFNB2	2.05e-04	8	95	2	18245384
Pubmed	The identification of different endothelial cell populations within the mouse proepicardium.	KDR HNF4A	2.05e-04	8	95	2	21932312
Pubmed	Temporally compartmentalized expression of ephrin-B2 during renal glomerular development.	EFNB2 KDR	2.05e-04	8	95	2	11729236
Pubmed	Eph:ephrin-B1 forward signaling controls fasciculation of sensory and motor axons.	EFNB2 EPHA1	2.05e-04	8	95	2	24056079
Pubmed	A QUICK screen for Lrrk2 interaction partners--leucine-rich repeat kinase 2 is involved in actin cytoskeleton dynamics.	ACTBL2 ACTG2 ACTR2	2.25e-04	43	95	3	20876399
Pubmed	Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and FcγR signaling.	TLR4 ALOX5	2.62e-04	9	95	2	23112187
Pubmed	Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model.	TLR4 PRKDC	2.62e-04	9	95	2	16239576
Cytoband	Xp11.22	CENPVL2 CENPVL3 HUWE1 CENPVL1	5.03e-06	54	95	4	Xp11.22
Cytoband	Ensembl 112 genes in cytogenetic band chr3p21	CACNA1D RNF123 NISCH SMARCC1 SLC38A3	5.23e-04	316	95	5	chr3p21
GeneFamily	Structural maintenance of chromosomes proteins\|Cohesin complex	SMC5 SMC1B	2.98e-04	7	69	2	761
Coexpression	WOOD_EBV_EBNA1_TARGETS_DN	IPO7 SGK1 MACF1 EPB41L3 ACTR2	7.25e-07	48	92	5	M19460
Coexpression	BOQUEST_STEM_CELL_DN	MET RNASE1 VWF EFNB2 PIK3C2B LPCAT4 KDR BCAR3	1.03e-06	218	92	8	M1578
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HENDO	SLC38A2 RNASE1 VWF EFNB2 PLA2G4C IGFBP4 STARD4 IKBKE RAPGEF3 SGK1 TLR4 KDR SLC38A3	1.34e-05	888	92	13	M39049
Coexpression	MENON_FETAL_KIDNEY_9_ENDOTHELIAL_CELLS	RNASE1 EFNB2 IGFBP4 KDR ACTR2	3.04e-05	102	92	5	M39259
Coexpression	AIZARANI_LIVER_C10_MVECS_1	RNASE1 VWF EFNB2 IGFBP4 SGK1 KDR RUNX1T1	4.62e-05	269	92	7	M39114
Coexpression	GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN	GUCY1A1 IKBKE NISCH DECR2 LRRC14 PM20D2	4.91e-05	185	92	6	M8680
Coexpression	AIZARANI_LIVER_C13_LSECS_2	RNASE1 EFNB2 IGFBP4 SGK1 NISCH TLR4 KDR	6.36e-05	283	92	7	M39117
Coexpression	GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP	SLC38A2 CACNA1D IPO7 SMARCC1 PRKDC HUWE1	6.96e-05	197	92	6	M8022
Coexpression	GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_DN	TRPM6 STARD4 TLR4 UBA6 PLCB2 TGM6	7.16e-05	198	92	6	M3557
Coexpression	GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN	TRPM6 PXDNL TLR4 UBA6 PLCB2 TGM6	7.36e-05	199	92	6	M3554
Coexpression	AIZARANI_LIVER_C32_MVECS_3	SLC38A2 RNASE1 VWF SGK1 TLR4	8.03e-05	125	92	5	M39131
Coexpression	MIKKELSEN_MEF_LCP_WITH_H3K4ME3	MASP1 RNF123 IKBKE TLR4 ACTG2	8.99e-05	128	92	5	M1966
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RNASE1 VWF EFNB2 PLA2G4C RGS7BP PIK3C2B KDR BCAR3 ZFPM2	3.65e-10	194	95	9	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RNASE1 VWF EFNB2 PLA2G4C RGS7BP PIK3C2B KDR BCAR3 ZFPM2	3.65e-10	194	95	9	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RNASE1 VWF EFNB2 RGS7BP PIK3C2B MACF1 KDR ZFPM2	9.12e-09	194	95	8	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RNASE1 VWF EFNB2 PLA2G4C RGS7BP PIK3C2B KDR BCAR3	9.49e-09	195	95	8	56efeb58df19f357d7d5ce87348d4f196a595421
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RNASE1 VWF EFNB2 IGFBP4 SGK1 TLR4 KDR RUNX1T1	1.16e-08	200	95	8	b1be27d134a8633e3e7862c6a0d7be2001d387f0
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RNASE1 VWF EFNB2 IGFBP4 SGK1 TLR4 KDR RUNX1T1	1.16e-08	200	95	8	ced14d83222dbebca85c40540e76824e683354f3
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF EFNB2 PLA2G4C RGS7BP PIK3C2B KDR BCAR3	1.44e-07	185	95	7	808d5e880069aff8866cd2c733b9fe568a37701f
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF EFNB2 PLA2G4C RGS7BP PIK3C2B KDR BCAR3	1.55e-07	187	95	7	dffa8447c2f3fdacf39a7258c6b4e81a25245041
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RNASE1 VWF EFNB2 RGS7BP PIK3C2B KDR ZFPM2	1.93e-07	193	95	7	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	wk_20-22-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	RNASE1 VWF EFNB2 IGFBP4 PIK3C2B RAPGEF3 KDR	2.06e-07	195	95	7	a432d69b0172211ee4d53675936a1dc9ce1ae1f0
ToppCell	5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNASE1 VWF EFNB2 IGFBP4 PIK3C2B RAPGEF3 KDR	2.14e-07	196	95	7	ae46d4b00be92e64e46252dcc156161b171eded4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	VWF EFNB2 PIK3C2B KDR RUNX1T1 ADARB1 RYR3	2.14e-07	196	95	7	8ad8efb631164b46f0c082572270188e5ead20bf
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	VWF EFNB2 IGFBP4 PIK3C2B KDR RUNX1T1 RYR3	2.14e-07	196	95	7	22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	VWF EFNB2 PIK3C2B KDR RUNX1T1 ADARB1 RYR3	2.14e-07	196	95	7	9606ea7e42f707e69ea891b3521037613b9675f5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	VWF EFNB2 IGFBP4 PIK3C2B KDR RUNX1T1 RYR3	2.14e-07	196	95	7	adee900dcd16dbaba15c58bdcace09ba20214950
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	VWF EFNB2 SGK1 KDR RUNX1T1 ADARB1 RYR3	2.21e-07	197	95	7	cd509e49bbdbf991cc5913960ff3ef275ad40628
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	VWF EFNB2 PIK3C2B SGK1 KDR RUNX1T1 RYR3	2.29e-07	198	95	7	07701c73137947ed4a27e225975329235bbb8734
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RNASE1 VWF EFNB2 IGFBP4 PIK3C2B KDR RUNX1T1	2.29e-07	198	95	7	953630dbe3154b1b102b87de0feca2cbf124eabe
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	VWF EFNB2 PIK3C2B SGK1 KDR RUNX1T1 RYR3	2.29e-07	198	95	7	fa84bf8533d1b91d2c2bcf06b710670605072b89
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RNASE1 VWF EFNB2 IGFBP4 PIK3C2B KDR RUNX1T1	2.29e-07	198	95	7	8e45551224fbb30c0658ad47dd98335ecf165437
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNASE1 VWF EFNB2 IGFBP4 PIK3C2B RAPGEF3 KDR	2.37e-07	199	95	7	b15304d3d3f6c254969b54a61bee3d9f368840b2
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RNASE1 VWF EFNB2 IGFBP4 SGK1 KDR RUNX1T1	2.37e-07	199	95	7	8b62d43af8b2ebb4c1b2d068d50beaf35728dbe7
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RNASE1 VWF EFNB2 IGFBP4 SGK1 KDR RUNX1T1	2.37e-07	199	95	7	da5a88749d859d535daa030d0974485906cc0ba7
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	RNASE1 VWF PLA2G4C RGS7BP PIK3C2B MACF1 KDR	2.45e-07	200	95	7	2d07237022b409c4fac6fcf99b68c8affb3007cd
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	RNASE1 VWF PLA2G4C RGS7BP PIK3C2B MACF1 KDR	2.45e-07	200	95	7	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RNASE1 VWF EFNB2 IGFBP4 SGK1 KDR RUNX1T1	2.45e-07	200	95	7	dba96cda5f3b780a3d4171b61bc8aaddc1f5d466
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RNASE1 VWF EFNB2 IGFBP4 SGK1 KDR RUNX1T1	2.45e-07	200	95	7	7a69ad5b6c84f1aebacea5cacb9bc5c63dfd1dac
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	RNASE1 VWF PLA2G4C RGS7BP PIK3C2B MACF1 KDR	2.45e-07	200	95	7	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	LPS-IL1RA-Endothelial-Epi-like-Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RNASE1 APEX2 ACTG2 EPB41L3 HNF4A EPHA1	5.18e-07	138	95	6	5f8ac8f67e34a7cf560099208e6884102532391e
ToppCell	droplet-Heart-nan-3m-Endothelial-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFNB2 SGK1 UBA6 KDR NUP214 ADARB1	1.10e-06	157	95	6	d85a2f56ae313baa9738e81d2756ce1fe1ba50db
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TRPM6 VWF RAPGEF3 LPCAT4 RUNX1T1 ZFPM2	1.58e-06	167	95	6	d7fe24cdc4b55a9555ce9e20699f5036b88148e9
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RNASE1 VWF EFNB2 IGFBP4 SGK1 KDR	1.64e-06	168	95	6	37249f38f8f04ec5743097259de67b106ca2b02f
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CACNA1D VWF IGFBP4 MACF1 KDR ADARB1	1.75e-06	170	95	6	7fa022471e14ac8a3bc147c793368a4d56a8e591
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PXDNL ANKS1B ACTG2 PLCL1 ADARB1 ZFPM2	1.94e-06	173	95	6	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNASE1 VWF IGFBP4 NETO1 KDR ADARB1	2.44e-06	180	95	6	97e0dcb7cfbba60a782824c5e23995058609fcd4
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TRPM6 MASP1 VWF RAPGEF3 RUNX1T1 ZFPM2	2.44e-06	180	95	6	27e8bbee388e64dd79d70b160b76d45b1f398006
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNASE1 VWF EFNB2 IGFBP4 RAPGEF3 KDR	2.60e-06	182	95	6	0346f81bbb1f309f3e9d063b20547d548d09472c
ToppCell	3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNASE1 VWF EFNB2 IGFBP4 RAPGEF3 KDR	2.77e-06	184	95	6	842473fa415575441b595073a994b6d621169776
ToppCell	P03\|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CACNA1D IGFBP4 NISCH MACF1 ADARB1 EPHA1	2.86e-06	185	95	6	a07dbe1f76e40734a28826423a5cc64b8e56af5e
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TRPM6 VWF RAPGEF3 LPCAT4 RUNX1T1 ZFPM2	3.04e-06	187	95	6	e35716f8b482be3bf5ab79f087a9caf67a9d197a
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNASE1 VWF EFNB2 IGFBP4 NETO1 KDR	3.04e-06	187	95	6	0ef82111b9049cc7ee78d64d240e1f10ab14d6b6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RNASE1 VWF EFNB2 IGFBP4 SGK1 KDR	3.04e-06	187	95	6	a555a4af7946dec14a6b176ace4a4c2ecfd7f59e
ToppCell	3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNASE1 VWF EFNB2 IGFBP4 RAPGEF3 KDR	3.04e-06	187	95	6	25efb82afe863a853ecdd781ad89026c993aaa67
ToppCell	wk_08-11-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	VWF EFNB2 IGFBP4 PIK3C2B NETO1 KDR	3.04e-06	187	95	6	a27aa97aa6508a3ffe92c2b6bb0511a95650a390
ToppCell	wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	VWF EFNB2 IGFBP4 PIK3C2B RAPGEF3 KDR	3.14e-06	188	95	6	366a2d59b9c81d8a7659749f9c07efa46b49a39a
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	RGS7BP ANKS1B ACTG2 MACF1 ADARB1 RYR3	3.14e-06	188	95	6	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNASE1 VWF EFNB2 IGFBP4 RAPGEF3 KDR	3.14e-06	188	95	6	0026c9479b30fb39daa91cfa220a88f9c9e65fe7
ToppCell	Fibroblast-A\|World / shred on cell class and cell subclass (v4)	CACNA1D IGFBP4 MACF1 RUNX1T1 ADARB1 PPP4R4	3.14e-06	188	95	6	6740bed5fb8f45b6eea17041894b804214c2a4ae
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNASE1 VWF EFNB2 IGFBP4 RAPGEF3 KDR	3.23e-06	189	95	6	db09d591b885ce2bc9e353f08b6694e2192582e1
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	RGS7BP ANKS1B ACTG2 MACF1 ADARB1 RYR3	3.23e-06	189	95	6	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RNASE1 VWF EFNB2 RGS7BP GUCY1A1 KDR	3.23e-06	189	95	6	e82211b9dc7540e7a183be2cbcfae39fdf503949
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RNASE1 EFNB2 PLA2G4C GUCY1A1 PIK3C2B KDR	3.33e-06	190	95	6	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	VWF EFNB2 PIK3C2B RUNX1T1 ADARB1 RYR3	3.44e-06	191	95	6	b2c86cde341fe350143658c8a8a4a9edbce3f19b
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RNASE1 VWF EFNB2 PLA2G4C PIK3C2B KDR	3.44e-06	191	95	6	a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCell	5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWF IGFBP4 RAPGEF3 LPCAT4 EPB41L3 RYR3	3.54e-06	192	95	6	eafead22bba48ac5ee568faa8946c444445c1034
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-immature_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	VWF IGFBP4 RAPGEF3 KDR SLC38A3 ZFPM2	3.54e-06	192	95	6	5af3b2b38495e925497c48f605d618bbf970965d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RNASE1 VWF IGFBP4 RGS7BP PIK3C2B RYR3	3.54e-06	192	95	6	1ee4783051ec94ea94600f040edcb385fc4289f1
ToppCell	LPS-IL1RA+antiTNF-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RNASE1 VWF EFNB2 RGS7BP PIK3C2B KDR	3.54e-06	192	95	6	04f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF EFNB2 RGS7BP PIK3C2B KDR BCAR3	3.54e-06	192	95	6	0aeb5351275c0a91151ea2d52b2cdde172da6731
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RNASE1 VWF EFNB2 RGS7BP PIK3C2B KDR	3.54e-06	192	95	6	c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RNASE1 VWF IGFBP4 RGS7BP KDR RYR3	3.54e-06	192	95	6	25cb6cc6cbf8dc20139d938adfc02ed7a8c3dfb6
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	VWF EFNB2 PIK3C2B NETO1 RAPGEF3 KDR	3.54e-06	192	95	6	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CACNA1D IGFBP4 NISCH MACF1 ADARB1 EPHA1	3.54e-06	192	95	6	0afb9dbe468e0be442c326e11c5fc0f699b32f23
ToppCell	facs-Brain_Non-Myeloid-Striatum\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NETO1 NISCH ANKS1B EPB41L3 SH2D5 RYR3	3.65e-06	193	95	6	d8ccfb780a75bdf9141f41fb29a076958601ebb4
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RNASE1 VWF EFNB2 RGS7BP PIK3C2B KDR	3.65e-06	193	95	6	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA1D IGFBP4 NISCH MACF1 ADARB1 PPP4R4	3.65e-06	193	95	6	8d05805295c5d3aa93aeb38be5fbefa81e1be1f0
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RNASE1 VWF EFNB2 RGS7BP PIK3C2B KDR	3.65e-06	193	95	6	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA1D IGFBP4 NISCH MACF1 ADARB1 PPP4R4	3.65e-06	193	95	6	1b2cc627b2aa002b442358bd1188d470e67ce7d9
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	VWF EFNB2 IGFBP4 RGS7BP PIK3C2B RYR3	3.65e-06	193	95	6	287e756d5fd3bd2931c168da24beaa0d02a350ae
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RNASE1 VWF EFNB2 PIK3C2B KDR RUNX1T1	3.76e-06	194	95	6	f76808666fb875fc787751cbfd924d9be20a8192
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RNASE1 VWF EFNB2 RGS7BP PIK3C2B KDR	3.76e-06	194	95	6	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RNASE1 VWF EFNB2 RGS7BP PIK3C2B KDR	3.76e-06	194	95	6	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RNASE1 IGFBP4 RGS7BP PIK3C2B KDR RUNX1T1	3.76e-06	194	95	6	b490fffc94f005dff9a34ce34d80ca776e3a1387
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RNASE1 VWF EFNB2 PIK3C2B KDR RUNX1T1	3.76e-06	194	95	6	f5706ab6bc803606c4640ddd606617e4e797ccc9
ToppCell	Control-Endothelial\|Control / Disease state, Lineage and Cell class	VWF EFNB2 IGFBP4 KDR RUNX1T1 ZFPM2	3.76e-06	194	95	6	485fe5538fabec457b9a51feb641f2a91cbf4e18
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA1D IGFBP4 NISCH MACF1 ADARB1 PPP4R4	3.87e-06	195	95	6	b616ee6f1d878935d293c8e0a8bbc5b4385301f0
ToppCell	background-Endothelial_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	RNASE1 VWF IGFBP4 RGS7BP KDR RUNX1T1	3.87e-06	195	95	6	c7d60dabfc7cb310e002cab10003dadfcc34fe33
ToppCell	LV-09._Endothelium_I\|World / Chamber and Cluster_Paper	VWF EFNB2 RAPGEF3 SGK1 KDR RUNX1T1	3.87e-06	195	95	6	19e0a6c3eae1615aaa39767300acd937dfcb2a7f
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1D NISCH MACF1 HUWE1 ZCCHC7 EPB41L3	3.87e-06	195	95	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Children_(3_yrs)-Endothelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VWF EFNB2 PLA2G4C KDR RUNX1T1 ZFPM2	3.87e-06	195	95	6	094cf6591daa5ffad36e44122b6f524a3a34c2fd
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1D NISCH MACF1 HUWE1 ZCCHC7 EPB41L3	3.87e-06	195	95	6	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	PND07-Mesenchymal-Mesenchymal_structural\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA1D IGFBP4 NISCH MACF1 ADARB1 PPP4R4	3.87e-06	195	95	6	2f9a274b26fc528a85f50933ec2f4db1dc9da0ca
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RNASE1 EFNB2 IGFBP4 SGK1 TLR4 KDR	3.99e-06	196	95	6	d323f7dc41380446e5967c69832bea88351a9331
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RNASE1 EFNB2 IGFBP4 SGK1 TLR4 KDR	3.99e-06	196	95	6	65d882c6e7f6d5778b8a5fd4fdaf012e1b9f6100
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA1D IGFBP4 MACF1 RUNX1T1 ADARB1 PPP4R4	3.99e-06	196	95	6	2a885eed52f9b002c7995e11e450c7e8d7ae69e6
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA1D IGFBP4 MACF1 RUNX1T1 ADARB1 PPP4R4	3.99e-06	196	95	6	14246f00c90741a5f8683f377e22e3a7c99661b9
ToppCell	MatrixFB\|World / shred on cell class and cell subclass (v4)	CACNA1D IGFBP4 GUCY1A1 ACTG2 MACF1 ADARB1	4.11e-06	197	95	6	e325de44e32021a36fffb7b7e88167b46bb051c7
ToppCell	PND03-Mesenchymal\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA1D IGFBP4 GUCY1A1 ACTG2 MACF1 ADARB1	4.11e-06	197	95	6	e3053ef8f604b6892c21c03e12612b49d3d30f23
ToppCell	nucseq-Endothelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	VWF EFNB2 IGFBP4 KDR RUNX1T1 ZFPM2	4.11e-06	197	95	6	ebf9be068eaa658493fa7884fd19f34642922acb
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	VWF SGK1 KDR RUNX1T1 ADARB1 RYR3	4.11e-06	197	95	6	412cb5f37df57121ddd1492021445479c7cbccbf
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNASE1 VWF EFNB2 IGFBP4 TLR4 KDR	4.11e-06	197	95	6	b18f2c14d6720f6ae8520c0800356f4a57393ad3
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RNASE1 VWF EFNB2 IGFBP4 PIK3C2B RUNX1T1	4.23e-06	198	95	6	1b9200e30f1d9b91bb0c6411c4f95208aedbe161
ToppCell	5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNASE1 VWF EFNB2 IGFBP4 GUCY1A1 RAPGEF3	4.23e-06	198	95	6	8a55589b9244283e4b0b423a4a6d6202e8e0fec9
ToppCell	ILEUM-inflamed-(7)_CD36+_endothelial_cells\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RNASE1 VWF EFNB2 IGFBP4 RAPGEF3 KDR	4.23e-06	198	95	6	05d6558c7990ad2277db999025a073d29b273dfc
ToppCell	5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNASE1 VWF EFNB2 IGFBP4 GUCY1A1 RAPGEF3	4.23e-06	198	95	6	d1f54ed3ef5e05ebda7da999e172d168dc6802cd
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNASE1 VWF EFNB2 IGFBP4 RAPGEF3 KDR	4.23e-06	198	95	6	e9e98c20ff7b3f3851db86381550ce7085e2db9e
ToppCell	5'-Adult-Distal_Rectal-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNASE1 VWF EFNB2 IGFBP4 GUCY1A1 RAPGEF3	4.23e-06	198	95	6	8d6b0b9da7c1e64155cbcbb04ad38d129a29030c
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RNASE1 VWF EFNB2 IGFBP4 PIK3C2B RUNX1T1	4.23e-06	198	95	6	7e2d6e21b2b3d5a4a9f786890ec6ba2688a506cc
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RNASE1 VWF EFNB2 IGFBP4 PIK3C2B RUNX1T1	4.23e-06	198	95	6	55378e15360f867c9500b03293814965562ae55d
ToppCell	5'-GW_trimst-2-SmallIntestine-Endothelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNASE1 VWF EFNB2 IGFBP4 RAPGEF3 KDR	4.23e-06	198	95	6	f7a957e8f09d54a55a5dbecfaa9cdf01e6fd543d
Drug	AC1OAGGW	ACTL8 PIK3C2B ACTBL2 ACTG2 PLCB2 EPB41L3 F2 TG	1.57e-06	203	91	8	CID006857364
Drug	AC1MU1S9	ACTL8 GUCY1A1 PIK3C2B NETO1 SGK1 ACTBL2 ACTG2 PLCB2 TSHB NUP214 F2 ALOX5	2.92e-06	572	91	12	CID000003733
Drug	wartmannin	SLC38A2 MET ACTL8 STRAP PIK3C2B RAPGEF3 SGK1 SLC38A4 ACTBL2 ACTG2 KDR PRKDC F2 TG	3.97e-06	811	91	14	CID000005691
Drug	AC1Q5THZ	VWF ACTL8 ACTBL2 TLR4 ACTG2 PLCB2 NUP214 F2 ALOX5 PADI1 TG	5.18e-06	502	91	11	CID000001959
Drug	lithium aluminum hydride	SLC38A2 ACTL8 NETO1 SLC38A4 ACTG2 PLCB2 TSHB F2 TG	5.46e-06	320	91	9	CID000028112
Drug	quinacrine	CRYGA ACTL8 ACTBL2 ACTG2 TSHB PLCL1 F2 ALOX5	5.95e-06	243	91	8	CID000000237
Drug	AC1OAGFB	VWF PLA2G4C ACTL8 PIK3C2B RAPGEF3 ACTBL2 ACTG2 PLCB2 TSHB F2 TG	1.01e-05	539	91	11	CID006857345
Drug	AC1L1KC5	CACNA1D ACTL8 RAPGEF3 NISCH ACTBL2 ACTG2 PLCB2 F2 ALOX5 RYR3 TG	1.05e-05	541	91	11	CID000005428
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	MET IKBKE MARF1 OCA2 HUWE1 ADARB1 EPHA1	1.25e-05	193	91	7	6981_UP
Drug	AC1OAGKW	ACTL8 PIK3C2B SGK1 ACTG2 PLCB2 PLCL1 F2	1.25e-05	193	91	7	CID006857413
Drug	LMWH	MET MASP1 VWF AOC1 IGFBP4 ACTL8 NETO1 SGK1 ACTG2 KDR F2 RYR3	1.30e-05	663	91	12	CID000000772
Drug	histamine	VWF AOC1 IGFBP4 ACTL8 ACTBL2 TLR4 ACTG2 KDR PLCB2 TSHB ALOX5	1.44e-05	560	91	11	CID000000774
Drug	3,5-diiodo-L-thyronine	IGFBP4 SLC38A4 TSHB TG	1.59e-05	38	91	4	CID000092859
Drug	H2O2	MET AOC1 ACTL8 APEX2 PIK3C2B NETO1 PXDNL ACTBL2 ACTG2 KDR PLCB2 TGM6 F2 ALOX5 RYR3 TG	1.67e-05	1183	91	16	CID000000784
Drug	U46619	CACNA1D VWF ACTL8 ACTBL2 PLCB2 F2 ALOX5 RYR3	1.89e-05	285	91	8	CID000005618
Drug	guanosine 3',5'-cyclic monophosphoric acid	TRPM6 CACNA1D ACTL8 GUCY1A1 RAPGEF3 ACTG2 PLCB2 F2 ALOX5 RYR3 RING1	1.91e-05	577	91	11	CID000000295
Drug	plakin	ACTL8 ACTBL2 ACTG2 MACF1 F2	1.95e-05	82	91	5	CID000018752
Drug	sodium	TRPM6 SLC38A2 CACNA1D MET ACTL8 SGK1 SLC38A4 ACTBL2 ACTG2 PLCB2 HUWE1 F2 SLC38A3 RYR3	2.20e-05	944	91	14	CID000000923
Drug	D-myo-inositol 1,4-bisphosphate	ACTL8 ACTBL2 ACTG2 PLCB2 F2	2.46e-05	86	91	5	CID000000805
Drug	lithium chromate	SLC38A2 ACTL8 NETO1 SLC38A4 ACTBL2 TSHB SLC38A3 TG	2.48e-05	296	91	8	CID000026627
Drug	(2S,3R)-Sphingosine	PLA2G4C ACTL8 PIK3C2B ACTBL2 ACTG2 PLCB2 TSHB F2 RYR3	2.58e-05	389	91	9	CID000001104
Drug	methylhydrazine	MET RUNX1T1 HNF4A	2.71e-05	15	91	3	CID000006061
Drug	genistein	CACNA1D MET EFNB2 IGFBP4 ACTL8 PIK3C2B ACTBL2 ACTG2 KDR PLCB2 SMC5 F2 ALOX5 ZFPM2 RYR3	3.45e-05	1117	91	15	CID005280961
Drug	2BrP	MET RNASE1 VWF F2 HNF4A	3.60e-05	93	91	5	CID006540269
Drug	manidipine	CACNA1D ACTL8 ACTBL2 ACTG2 RYR3	3.98e-05	95	91	5	CID000004008
Drug	AC1Q6LQU	ACTL8 ACTBL2 ACTG2 F2	4.06e-05	48	91	4	CID000072380
Drug	AC1L1K7T	MET VWF IGFBP4 PIK3C2B NETO1 KDR PLCB2 NUP214 BCAR3 RUNX1T1 ALOX5	4.37e-05	632	91	11	CID000005376
Drug	Sch 40120	ALOX5 TG	4.73e-05	3	91	2	CID003081026
Drug	forskolin from Coleus forskohlii	SLC38A2 CACNA1D IGFBP4 ACTL8 PIK3C2B RAPGEF3 SLC38A4 ACTBL2 ACTG2 PLCB2 TSHB F2 RYR3 TG	4.76e-05	1013	91	14	CID000003413
Drug	Nsc687160	ACTL8 ACTBL2 ACTG2	4.83e-05	18	91	3	CID005459290
Drug	arabinosyladenine	CACNA1D RNASE1 VWF ACTL8 GUCY1A1 PIK3C2B RAPGEF3 ACTBL2 ACTG2 F2 ADARB1 RYR3	5.07e-05	762	91	12	CID000000191
Drug	enantio-PAF-C16	VWF ACTL8 ACTBL2 ACTG2 PLCB2 F2 ALOX5	5.61e-05	244	91	7	CID000002499
Drug	dithiotreitol	RNASE1 PLAAT1 VWF ACTL8 ACTBL2 ACTG2 PADI1 RYR3 TG	5.61e-05	430	91	9	CID000019001
Drug	tolytoxin	ACTL8 ACTBL2 ACTG2	5.71e-05	19	91	3	CID006440827
Drug	prostacyclin sodium salt	VWF ACTL8 NETO1 ACTG2 TSHB F2 ALOX5	6.54e-05	250	91	7	CID000000159
Drug	PTK/ZK	MET VWF ACTL8 ACTBL2	7.48e-05	56	91	4	CID000151193
Drug	NSC312786	ACTL8 ACTBL2 ACTG2	7.80e-05	21	91	3	CID000329495
Drug	AC1L8NVR	ACTL8 ACTBL2 ACTG2	7.80e-05	21	91	3	CID000384633
Drug	O-Ir	VWF EFNB2 IGFBP4 KDR	8.02e-05	57	91	4	CID000448249
Drug	D-myo-inositol-1,4,5-triphosphate	CACNA1D ACTL8 RAPGEF3 ACTBL2 ACTG2 PLCB2 TSHB PLCL1 F2 RYR3	9.06e-05	568	91	10	CID000000806
Drug	AGEPC	VWF ACTL8 NETO1 ACTBL2 ACTG2 PLCB2 F2 ALOX5	9.08e-05	356	91	8	CID000461545
Drug	NCGC 00229600	TSHB TG	9.43e-05	4	91	2	ctd:C556685
Drug	Rdv peptide	VWF F2	9.43e-05	4	91	2	CID000196843
Drug	NSC-65828	RNASE1 AOC1	9.43e-05	4	91	2	CID005351857
Drug	potassium perchlorate	TSHB TG	9.43e-05	4	91	2	ctd:C009006
Drug	ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A	ALKBH4 RNF123 IGFBP4 ACTL8 SGK1 LPCAT4	9.98e-05	185	91	6	5235_DN
Drug	aluminum fluoride	MASP1 IGFBP4 ACTL8 ACTBL2 PLCB2 WDFY3 TG	1.01e-04	268	91	7	CID000002124
Drug	AC1L8UHC	TLR4 SMC5 TG	1.03e-04	23	91	3	CID000432954
Drug	blebbistatin	EFNB2 ACTL8 ACTBL2 ACTG2 EPHA1	1.03e-04	116	91	5	CID003476986
Drug	triphosphoinositide	TRPM6 PLA2G4C ACTL8 ACTG2 DECR2 PLCB2 F2	1.13e-04	273	91	7	CID009543520
Drug	glutamate	TRPM6 APIP SLC38A2 CACNA1D ACTL8 SGK1 SLC38A4 ACTBL2 ACTG2 PLCB2 ADARB1 SLC38A3 RYR3	1.14e-04	962	91	13	CID000000611
Drug	resveratrol; Up 200; 50uM; MCF7; HG-U133A	MET PLA2G4C MARF1 DECR2 TSHB RUNX1T1	1.16e-04	190	91	6	595_UP
Drug	methyl ethyl ketone	MET MASP1 VWF ACTL8 RAPGEF3 NISCH ACTG2 KDR F2 SLC38A3	1.19e-04	587	91	10	CID000006569
Drug	GTP[S]	CACNA1D MASP1 ACTL8 NISCH ACTBL2 ACTG2 PLCB2 F2 RYR3 TG	1.25e-04	591	91	10	CID000001764
Drug	Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A	SGK1 TESK2 WDFY3 BCAR3 ZNF688 ALOX5	1.26e-04	193	91	6	1148_UP
Drug	Fortress	RNASE1 VWF F2	1.33e-04	25	91	3	CID000091655
Drug	AC1L1UD1	RNASE1 VWF F2	1.33e-04	25	91	3	CID000035754
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; MCF7; HT_HG-U133A	RNF123 IKBKE ACTG2 CHD3 LRRC14 ADARB1	1.37e-04	196	91	6	3248_DN
Drug	Heliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A	CACNA1D ACTL8 CHD3 LRRC14 WDFY3 EPHA1	1.37e-04	196	91	6	4739_DN
Drug	tetraethylenepentamine pentahydrochloride; Down 200; 100uM; HL60; HG-U133A	MASP1 PLCB2 NUP214 SMC5 PADI1 TG	1.37e-04	196	91	6	412_DN
Drug	(+,-)-Octopamine hydrochloride [770-05-8]; Up 200; 21uM; HL60; HT_HG-U133A	MASP1 PLA2G4C CTC1 ACTG2 HNF4A PPP4R4	1.41e-04	197	91	6	3112_UP
Drug	Mefexamide hydrochloride [3413-64-7]; Up 200; 12.6uM; MCF7; HT_HG-U133A	IKBKE LPCAT4 WDFY3 HUWE1 RUNX1T1 EPHA1	1.41e-04	197	91	6	7478_UP
Drug	Perphenazine [58-39-9]; Down 200; 10uM; MCF7; HT_HG-U133A	MET IKBKE LPCAT4 ACTG2 LRRC14 WDFY3	1.41e-04	197	91	6	1540_DN
Drug	5666823; Up 200; 100uM; MCF7; HG-U133A	MET TSHB HUWE1 HNF4A ZNF688 PADI1	1.41e-04	197	91	6	609_UP
Drug	vinblastine sulfate; Down 200; 0.1uM; MCF7; HT_HG-U133A	LPCAT4 OCA2 WDFY3 HNF4A ZNF688 PADI1	1.45e-04	198	91	6	7517_DN
Drug	Benoxinate hydrochloride [5987-82-6]; Down 200; 11.6uM; HL60; HG-U133A	RNF123 PIK3C2B IKBKE DECR2 RUNX1T1 MTMR9	1.45e-04	198	91	6	1976_DN
Drug	nitrendipine; Up 200; 10uM; MCF7; HG-U133A	MASP1 GUCY1A1 RAPGEF3 TSHB OCA2 PADI1	1.45e-04	198	91	6	336_UP
Drug	Pepstatin A [26305-03-3]; Down 200; 5.8uM; MCF7; HT_HG-U133A	CACNA1D MET RNF123 ACTL8 ADARB1 EPHA1	1.45e-04	198	91	6	3264_DN
Drug	Lisinopril [83915-83-7]; Up 200; 9uM; MCF7; HT_HG-U133A	MET IKBKE ZNF749 TSHB EPB41L3 EPHA1	1.49e-04	199	91	6	5504_UP
Drug	Trolox [53188-07-1]; Down 200; 16uM; MCF7; HT_HG-U133A	MET LPCAT4 UBA6 CHD3 ADARB1 MTMR9	1.49e-04	199	91	6	2883_DN
Drug	Hydrocortisone base [50-23-7]; Down 200; 11uM; MCF7; HT_HG-U133A	IPO7 TESK2 LRRC14 NUP214 ADARB1 MTMR9	1.53e-04	200	91	6	5284_DN
Drug	CID365768	RUNX1T1 ALOX5	1.57e-04	5	91	2	CID000365768
Drug	AP10	TSHB TG	1.57e-04	5	91	2	CID000193748
Drug	methenamine silver	ACTL8 IKBKE NETO1 ACTG2 BCAR3 RUNX1T1	1.57e-04	201	91	6	CID000004101
Drug	Calcium	TRPM6 CACNA1D AOC1 RAPGEF3 KDR F2 HNF4A ALOX5 RYR3	1.58e-04	493	91	9	ctd:D002118
Drug	AC1L9K72	PLAAT1 PLA2G4C NETO1 PLCB2 F2 SLC38A3 ALOX5	1.64e-04	290	91	7	CID000446872
Drug	beta-tocopherol	NETO1 F2 ALOX5	1.69e-04	27	91	3	CID000008989
Drug	AC1L1ERT	ACTL8 ACTBL2 ACTG2 F2	1.69e-04	69	91	4	CID000002920
Drug	NSC613009	ACTL8 RAPGEF3 ACTBL2 ACTG2 RYR3	1.76e-04	130	91	5	CID000003800
Drug	pyrene	ACTL8 APEX2 ACTBL2 ACTG2 ACTR2	1.83e-04	131	91	5	CID000031423
Drug	Barium	TRPM6 CACNA1D SGK1 F2	2.00e-04	72	91	4	ctd:D001464
Drug	ammonia	SLC38A2 AOC1 ACTL8 ACTBL2 ACTG2 OCA2 TGM6 ADARB1 PADI1	2.01e-04	509	91	9	CID000000222
Drug	POPC	PLA2G4C PIK3C2B NETO1 PLCB2 F2 SLC38A3 ALOX5	2.28e-04	306	91	7	CID000065167
Drug	azaspiracid	ACTL8 ACTBL2 ACTG2	2.32e-04	30	91	3	CID006451158
Drug	PF-00356231	VWF OCA2 F2	2.32e-04	30	91	3	CID000448942
Drug	AC1Q6T8I	RNASE1 NISCH PLCB2	2.32e-04	30	91	3	CID000000343
Drug	[(2R,3R,4R,5R,6R)-2-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-4-[(2S,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate	NETO1 ALOX5	2.35e-04	6	91	2	CID010395325
Drug	ipodate	TSHB TG	2.35e-04	6	91	2	CID000005241
Drug	8-bromoguanosine 3',5'-cyclic monophosphate	CACNA1D ACTL8 GUCY1A1 PIK3C2B ACTG2 F2 RYR3	2.37e-04	308	91	7	CID000001915
Drug	SB203580	SLC38A2 MET VWF ACTL8 RAPGEF3 ACTBL2 TLR4 ACTG2 TGM6 F2 ALOX5	2.52e-04	771	91	11	CID000176155
Drug	alpha-(methylamino)isobutyric acid	SLC38A2 SLC38A4 SLC38A3	2.56e-04	31	91	3	CID000075725
Drug	mu-I	NETO1 TSHB RUNX1T1 TG	2.72e-04	78	91	4	CID011987863
Drug	AC1L1HS4	ACTL8 ACTBL2 ACTG2	2.82e-04	32	91	3	CID000004267
Drug	NSC226080	SLC38A2 MET ACTL8 PIK3C2B SGK1 SLC38A4 ACTBL2 KDR NUP214 F2 RYR3	2.84e-04	782	91	11	CID000005040
Drug	AC1L9EF8	ACTL8 ACTBL2 ACTG2 TGM6	2.85e-04	79	91	4	CID000443315
Drug	ML-9	EFNB2 ACTL8 ACTBL2 ACTG2 F2	3.12e-04	147	91	5	CID000004217
Drug	trifluoperazine	ACTL8 ACTBL2 ACTG2 TSHB NUP214 F2 ALOX5	3.23e-04	324	91	7	CID000005566
Drug	ammonium perchlorate	TSHB TG	3.27e-04	7	91	2	ctd:C053506
Drug	O630	TSHB TG	3.27e-04	7	91	2	CID006327651
Drug	amino perchlorate	TSHB TG	3.27e-04	7	91	2	CID006327670
Disease	large cell carcinoma (is_implicated_in)	MET STRAP	2.75e-05	3	90	2	DOID:4552 (is_implicated_in)
Disease	sarcoma (is_marker_for)	MET KDR	9.15e-05	5	90	2	DOID:1115 (is_marker_for)
Disease	liver cirrhosis (is_marker_for)	TLR4 KDR F2 HNF4A	1.18e-04	82	90	4	DOID:5082 (is_marker_for)
Disease	Reperfusion Injury	EFNB2 TLR4 KDR ALOX5	1.62e-04	89	90	4	C0035126
Disease	Leukemia, Myelocytic, Acute	MET CTC1 SGK1 NUP214 RUNX1T1	1.92e-04	173	90	5	C0023467
Disease	venous thromboembolism, factor VII measurement	VWF F2 ZFPM2	2.14e-04	38	90	3	EFO_0004286, EFO_0004619
Disease	Moyamoya disease (implicated_via_orthology)	ACTBL2 ACTG2	2.55e-04	8	90	2	DOID:13099 (implicated_via_orthology)
Disease	autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology)	ACTBL2 ACTG2	2.55e-04	8	90	2	DOID:0110550 (implicated_via_orthology)
Disease	Baraitser-Winter syndrome 1 (implicated_via_orthology)	ACTBL2 ACTG2	2.55e-04	8	90	2	DOID:0081112 (implicated_via_orthology)
Disease	thoracic aortic aneurysm (implicated_via_orthology)	ACTBL2 ACTG2	2.55e-04	8	90	2	DOID:14004 (implicated_via_orthology)
Disease	venous thromboembolism, von Willebrand factor measurement	VWF F2 ZFPM2	2.89e-04	42	90	3	EFO_0004286, EFO_0004629
Disease	hepatocellular carcinoma (is_marker_for)	MET TLR4 SMARCC1 KDR F2 HNF4A	3.26e-04	301	90	6	DOID:684 (is_marker_for)
Disease	Thrombus	VWF GUCY1A1 F2	3.79e-04	46	90	3	C0087086
Disease	intestinal atresia (implicated_via_orthology)	ACTBL2 ACTG2	4.07e-04	10	90	2	DOID:10486 (implicated_via_orthology)
Disease	patent ductus arteriosus (implicated_via_orthology)	ACTBL2 ACTG2	4.07e-04	10	90	2	DOID:13832 (implicated_via_orthology)
Disease	Adenocarcinoma of lung (disorder)	TRPM6 SMARCC1 KDR PRKDC ALOX5	4.29e-04	206	90	5	C0152013
Disease	Carcinoma, Granular Cell	MET SMARCC1 KDR ALOX5	4.47e-04	116	90	4	C0205644
Disease	Adenocarcinoma, Tubular	MET SMARCC1 KDR ALOX5	4.47e-04	116	90	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	MET SMARCC1 KDR ALOX5	4.47e-04	116	90	4	C0205642
Disease	Carcinoma, Cribriform	MET SMARCC1 KDR ALOX5	4.47e-04	116	90	4	C0205643
Disease	Adenocarcinoma, Basal Cell	MET SMARCC1 KDR ALOX5	4.47e-04	116	90	4	C0205641
Disease	Adenocarcinoma	MET SMARCC1 KDR ALOX5	4.47e-04	116	90	4	C0001418
Disease	Thrombosis	VWF GUCY1A1 F2	4.57e-04	49	90	3	C0040053
Disease	serum albumin measurement	FAM117A AOC1 SLC38A4 SMARCC1 BEND3 MACF1 HNF4A PPP4R4	4.59e-04	592	90	8	EFO_0004535
Disease	cognitive inhibition measurement	TRPM6 PXDNL TGM6	4.85e-04	50	90	3	EFO_0007969
Disease	obesity (implicated_via_orthology)	TLR4 PLCB2 F2 HNF4A ADARB1	5.21e-04	215	90	5	DOID:9970 (implicated_via_orthology)
Disease	systemic scleroderma (is_marker_for)	VWF KDR F2	5.76e-04	53	90	3	DOID:418 (is_marker_for)
Disease	Acute Myeloid Leukemia, M1	MET SGK1 NUP214 RUNX1T1	5.92e-04	125	90	4	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	MET SGK1 NUP214 RUNX1T1	5.92e-04	125	90	4	C1879321
Disease	N-acetylputrescine measurement	AOC1 SLC38A3	5.95e-04	12	90	2	EFO_0800127
Disease	asthma (is_marker_for)	TLR4 KDR F2 ALOX5	6.10e-04	126	90	4	DOID:2841 (is_marker_for)
Disease	hyperglycemia (is_marker_for)	TSHB F2	7.02e-04	13	90	2	DOID:4195 (is_marker_for)
Disease	Congenital Hypothyroidism	TSHB TG	7.02e-04	13	90	2	C0010308
Disease	type 2 diabetes mellitus (is_marker_for)	CACNA1D TLR4 KDR F2	8.12e-04	136	90	4	DOID:9352 (is_marker_for)
Disease	Diabetic Neuralgia	SGK1 TLR4	8.17e-04	14	90	2	C0751074
Disease	Diabetic Neuropathies	SGK1 TLR4	8.17e-04	14	90	2	C0011882
Disease	Asymmetric Diabetic Proximal Motor Neuropathy	SGK1 TLR4	8.17e-04	14	90	2	C0271674
Disease	Symmetric Diabetic Proximal Motor Neuropathy	SGK1 TLR4	8.17e-04	14	90	2	C0271673
Disease	Diabetic Mononeuropathy	SGK1 TLR4	8.17e-04	14	90	2	C0271678
Disease	Diabetic Autonomic Neuropathy	SGK1 TLR4	8.17e-04	14	90	2	C0271686
Disease	Diabetic Amyotrophy	SGK1 TLR4	8.17e-04	14	90	2	C0271685
Disease	Diabetic Polyneuropathies	SGK1 TLR4	8.17e-04	14	90	2	C0271680
Disease	Diabetic Asymmetric Polyneuropathy	SGK1 TLR4	8.17e-04	14	90	2	C0393835
Disease	response to olanzapine	ANKS1B ZFPM2	9.41e-04	15	90	2	GO_0097333
Disease	venous thromboembolism, fibrinogen measurement	VWF HNF4A ZFPM2	1.14e-03	67	90	3	EFO_0004286, EFO_0004623
Disease	allergic rhinitis (is_marker_for)	TLR4 F2	1.21e-03	17	90	2	DOID:4481 (is_marker_for)
Disease	Uremia	SGK1 KDR	1.21e-03	17	90	2	C0041948
Disease	unipolar depression, bipolar disorder	PXDNL TLR4 PLCL1 ZCCHC7	1.35e-03	156	90	4	EFO_0003761, MONDO_0004985
Disease	Schizophrenia	SLC38A2 MET EFNB2 PLA2G4C TLR4 KDR F2 ADARB1 ACTR2	1.50e-03	883	90	9	C0036341
Disease	response to methotrexate, neurotoxicity	MACF1 PLCL1	1.52e-03	19	90	2	EFO_0011057, GO_0031427
Disease	response to angiotensin-converting enzyme inhibitor	TESK2 ANKS1B TG	1.77e-03	78	90	3	EFO_0005325
Disease	Deep Vein Thrombosis	KDR F2	1.86e-03	21	90	2	C0149871
Disease	Venous Thrombosis	KDR F2	1.86e-03	21	90	2	C0042487
Disease	venous thromboembolism, plasminogen activator inhibitor 1 measurement	VWF ZFPM2	1.86e-03	21	90	2	EFO_0004286, EFO_0004792
Disease	colorectal carcinoma (is_implicated_in)	EFNB2 STRAP	2.04e-03	22	90	2	DOID:0080199 (is_implicated_in)
Disease	venous thromboembolism, tissue plasminogen activator measurement	VWF ZFPM2	2.23e-03	23	90	2	EFO_0004286, EFO_0004791
Disease	hepatocellular carcinoma (is_implicated_in)	MET TLR4 KDR RYR3	2.32e-03	181	90	4	DOID:684 (is_implicated_in)
Disease	liver fibrosis measurement	VWF BCAR3 ZFPM2	2.34e-03	86	90	3	EFO_0010576
Disease	alanine measurement	SLC38A4 LRRC14 ALOX5	2.34e-03	86	90	3	EFO_0009765
Disease	household income	RNF123 PIK3C2B SMARCC1 LRRC14 PLCL1	2.42e-03	304	90	5	EFO_0009695
Disease	trans fatty acid measurement, trans/trans-18:2 fatty acid measurement	CACNA1D RYR3	2.43e-03	24	90	2	EFO_0006821, EFO_0006826
Disease	prostate specific antigen measurement	APIP TLR4 CHD3 PLCL1	2.66e-03	188	90	4	EFO_0004624
Disease	Hypertensive disease	VWF AOC1 GUCY1A1 TLR4	2.77e-03	190	90	4	C0020538
Disease	smoking status measurement	CACNA1D MET PXDNL TLR4 ANKS1B SMARCC1 CHD3 PLCL1 RUNX1T1 ADARB1	2.81e-03	1160	90	10	EFO_0006527
Disease	Bradycardia	CACNA1D NISCH	2.85e-03	26	90	2	C0428977

Protein segments in the cluster

Peptide	Gene	Start	Entry
LDYCPERGSAIDPHL	ALKBH4	156	Q9NXW9
LYHIPEFIPEARGLE	CATSPERG	446	Q6ZRH7
LVPVGRCHCEPGYEE	EPHA1	256	P21709
ETAECEFPPHLDVYI	CTC1	936	Q2NKJ3
TVPLRCLEEHYGTSP	BCAR3	256	O75815
QEYDEAGPPIVHRKC	ACTBL2	361	Q562R1
DICHPDTFSYPIERG	ACTL8	56	Q9H568
NHSYIFKREPPEGCE	FAM117A	331	Q9C073
PEYDEAGPSIVHRKC	ACTG2	361	P63267
CVPELFRLPEIYSLH	CRYGA	111	P11844
PRVYGVAPHCLDEGT	CENPVL1	216	A0A0U1RR11
YCPHADPGRPERLVF	APEX2	156	Q9UBZ4
ADDPVHYPRALCLFE	AOC1	406	P19801
ICPVYEGFSLPHLTR	ACTR2	166	P61160
GPEDGEIHPEICRLY	RGS7BP	111	Q6MZT1
QEKGSRCIPVYHPEF	OCA2	106	Q04671
RCIPVYHPEFITAEE	OCA2	111	Q04671
EVFEPPHYELCTLRG	NETO1	386	Q8TDF5
EPLGLHCIFIDDYLS	PADI1	621	Q9ULC6
HVPGPECRDLTSYAI	BEND3	661	Q5T5X7
CESPENPFHLYGKRE	ANKS1B	616	Q7Z6G8
CSIVDVEFLPVYHPS	LPCAT4	261	Q643R3
EFLHRPASGYVPEEI	RUNX1T1	431	Q06455
VLHRPFYPAVEGTLC	MTMR9	16	Q96QG7
PTEGLGECYHPRCDI	ZFPM2	776	Q8WW38
GECYHPRCDIFPGIV	ZFPM2	781	Q8WW38
EYLFEGHLCVLEPSV	IKBKE	351	Q14164
GNDYIVPRHCPELAE	HNF4A	246	P41235
IPLRTADSVFCPHYE	EFNB2	291	P52799
GDISPYTIPEEDRHC	IPO7	76	O95373
PDVEGDDCLPAYRHL	DECR2	6	Q9NUI1
CPPFYESDHPVRVLD	NUP214	231	P35658
CGDARIFSPHEPILE	ADARB1	451	P78563
GCFHLLDELPDTVYR	HUWE1	1446	Q7Z6Z7
HGIVDPENCRIVPYS	MACF1	2621	Q9UPN3
ECDLVYTFFHPLPRD	PIK3C2B	1466	O00750
DYCRRHKIPFPQVEE	PLA2G4C	426	Q9UP65
RDHGIPPYVDFRVFC	PXDNL	1146	A1KZ92
PRVYGVAPHCLDEGT	CENPVL2	216	P0DPI3
YHLVCLDPELDRAPE	CHD3	401	Q12873
PRVYGVAPHCLDEGT	CENPVL3	216	A0A0U1RRI6
CSPIIFEELEYHEPV	MARF1	961	Q9Y4F3
IFDIEDHPEVPCPYD	MASP1	231	P48740
PTICREDPEIHGYFR	CACNA1D	1821	Q01668
EDPEIHGYFRDPHCL	CACNA1D	1826	Q01668
DCKLPGYEPSRAEHL	EPB41L3	536	Q9Y2J2
FRPHPLLVEKGEYCQ	RING1	266	Q06587
EALLRPPFDACHAYV	OTOG	351	Q6ZRI0
CGAQDKEHPRYLIPE	APIP	16	Q96GX9
VAEYKTGPVLEHPDC	MET	81	P08581
AFVCHPEVLPIYTEL	SLC38A3	296	Q99624
HDPEVPVRYTIAICF	PPP4R4	406	Q6NUP7
ITLKTPHGDYIEFPC	ALOX5	86	P09917
ECHDLTGRFPDYPDA	IQCA1L	306	A6NCM1
TILCDPETLFYESPH	PPP1R35	206	Q8TAP8
TFCGTPEYLAPEVLH	SGK1	256	O00141
GRYCLEHLPAEFPSL	SH2D5	351	Q6ZV89
VGECIRTVPYTDPDH	PITRM1	866	Q5JRX3
RTHEDLYIIPIPNCD	IGFBP4	191	P22692
FAFVCHPEVLPIYSE	SLC38A4	341	Q969I6
ERHIIVACEGSPYVP	RNASE1	131	P07998
ECILHFLRLPIEDPY	SMARCC1	656	Q92922
ATPRPLHLGFLCEYD	PM20D2	101	Q8IYS1
GPIHCVRFSPDGELY	STRAP	266	Q9Y3F4
RTHPDEPLYSFCIGL	GTF3C3	761	Q9Y5Q9
YNSHRDPPEEEIPFC	UBA6	611	A0AVT1
IDPYVCIEIHGIPAD	PLCL1	746	Q15111
VGDKVPYDICRPDHS	RAPGEF3	556	O95398
RCPYEPHLAELDPTF	ZNF653	136	Q96CK0
IEHQEILSRPTPYEC	ZNF749	286	O43361
CLYLFFDLPHVPEAV	WDFY3	156	Q8IZQ1
DPPFHTAGRLIYCID	TRPM6	931	Q9BX84
DISEPPLHDFYCSRL	VWF	1261	P04275
YPDSVFGRLFDLCHP	SMC1B	511	Q8NDV3
FSFVCHPAVLPIYEE	SLC38A2	301	Q96QD8
CPCPEEIREELYDFH	RYR3	1886	Q15413
CYPHSLRAVERIPEE	RNF123	931	Q5XPI4
FLLDEDCVHYPLPEF	NISCH	1381	Q9Y2I1
PERYHCIEKGFVPLN	USP49	476	Q70CQ1
CPRPEIDEIFTSYHA	PLCB2	216	Q00722
CPGDLIEVFRPGYQH	PLAAT1	16	Q9HDD0
DFIYRTVEIPGCPLH	TSHB	76	P01222
PLPEYHVRIAGFDER	PRKDC	3711	P78527
PPVLFRHYPDIFEEC	ZNF688	261	P0C7X2
YVPRPTNHVGLFLDC	TRIM49D1	401	C9J1S8
HECPEREVYDPSPVS	ZCCHC7	361	Q8N3Z6
DYIHPVCLPDRETAA	F2	476	P00734
DLVYSIIDHIRPGPC	STARD4	61	Q96DR4
LPLDEHCERLPYDAS	KDR	811	P35968
FPHCEDYVASLGRPV	VWA3B	61	Q502W6
PEFLHQEACPFVGRE	TESK2	461	Q96S53
FLTYDICEVSPGPHL	SMC5	61	Q8IY18
LEEGVPPFQLCLHYR	TLR4	696	O00206
LDCGSPDIEVHTYPF	TG	2046	P01266
EVGLRYLPHEELFCS	ZNF45	91	Q02386
HTQEYPCPELVVRRG	TGM6	21	O95932
FPSEIPGICHFLDAY	GUCY1A1	646	Q02108
AELRTVVHPFPVDCY	LRRC14	421	Q15048